Primary information |
---|
ID | 11235 |
Uniprot ID | O43555 |
Description | Progonadoliberin-2 precursor (Progonadoliberin II) [Cleaved into- -Gonadoliberin-2 (Gonadoliberin II) (Luteinizing hormone-releasinghormone II) (LH-RH II) (Gonadotropin-releasing hormone II) (GnRH II)(Luliberin II); GnRH-associated peptide 2 (GnRH-associated peptideII)]. |
Organism | Homo sapiens |
Txonomy | Eukaryota; Opisthokonta; Metazoa; Eumetazoa; Bilateria; Deuterostomia; Chordata; Craniata; Vertebrata; Gnathostomata (jawed vertebrates); Teleostomi; Euteleostomi; Sarcopterygii; Dipnotetrapodomorpha; Tetrapoda; Amniota; Mammalia; Theria; Eutheria; Boreoeutheria; Euarchontoglires; Primates; Haplorrhini; Simiiformes; Catarrhini; Hominoidea (apes); Hominidae (great apes); Homininae; Homo; Homo sapiens (Human) |
Subcellular Location | Secreted |
Developmental Stage | NA |
Similarity | Belongs to the GnRH family. |
Tissue Specificity | Midbrain; expressed at significantly higher levels outside the brain (up to 30-fold); particularly in the kidney; bone marrow and prostate |
Post Translational Modification | NA |
Function | Stimulates the secretion of gonadotropins; it stimulates the secretion of both luteinizing and follicle-stimulating hormones |
Length | 120 |
Molecular Weight | 12918 |
Name | Gonadoliberin-2 |
Sequence | QHWSHGWYPG |
Sequence map | 10 (24-33) |
PDB ID | NA |
Drugpedia | NA |
Receptor | Q96P88;P30968;Q96P88 |
Domain | NA |
Pharmaceutical Use | NA
|